The global genotyping market is projected to reach USD 31.9 billion by 2023 from USD 11.8 billion in 2018, at a CAGR of 22.0%. This study involved the extensive use of both primary and secondary sources. The research process involved the stu... Read More >

BioMrieux, the international leader in in vitro diagnostics, today announced the acquisition of a controlling stake in Suzhou Hybiome Biomedical Engineering Co. Ltd. The company announced in July 2018 that it had acquired a minority stake in... Read More >

NEW YORK (GenomeWeb) Illumina plans to acquire Pacific Biosciences for approximately $1.2 billion in cash, the companies said on Thursday. Under the agreement, which has been approved by both companies boards of directors, Illumina will pay... Read More >

This story has been amended to correct errors and remove references to unrelated legal cases. NEW YORK (GenomeWeb) A jury has awarded Bio-Rad Laboratories $23.9 million in damages in the firms patent infringement suit against 10x Genomics,... Read More >

Bionano Genomics reported a 3 percent increase in third-quarter revenues after the market close recently . Fresh off its initial public offering in August , in which it raised $23.7 million in gross proceeds, the San Diego-based DNA analysi... Read More >

PerkinElmer Genomics has chosen BioDiscoverys NxClinical software for genomic data analysis for its services, BioDiscovery announced recently . The software will enable PerkinElmer Genomics to provide fast and accurate copy number variation... Read More >

The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9% over the forecast period 2018-2022 to reach a value of USD 2.7 billion by 2022, driven mainly by the rising prevalence of hematology co... Read More >

Danaher today reported a 7 percent year-over-year increase in its third quarter revenues with its diagnostic revenues up 3 percent. For the three months ended Sept. 28, 2018, the Washington-based conglomerate tallied $4.85 billion in total r... Read More >

Agena Biosciences and DaRui Biotechnology announced today that Agenas MassArray system has been cleared by the China Food and Drug Administration. The system is a mass spectrometry-based platform that Agena acquired from Sequenom in 2014 for... Read More >

The global hemostasis/coagulation analyzers market was valued at USD 3.65 billion in 2017 and is expected to grow at a CAGR of 9.9% over the period 2018 to 2026 to reach USD 9.55 billion by 2026, driven mainly by the growing incidence of blo... Read More >